Sustainable production of phyto-ingredients using hairy root cultures.

12.07.2017Published 13 days ago
Technology
TOSG20170712003
Offers
Plant cell suspension culture has been considered as an alternative to agricultural processes for producing valuable secondary metabolites. The biggest challenge of producing secondary metabolites from plant cell suspension cultures is that secondary metabolites are usually produced by specialised cells and/or at distinct developmental stages. Some compounds are not able to be synthesised if the cells remain undifferentiated. Therefore, undifferentiated plant cell suspension cultures often lose, partially or totally, their biosynthetic ability to accumulate secondary products.

New catalysts for sustainable liquid biofuels

12.07.2017Published 13 days ago
Technology
TOSG20170712002
Offers
The Fischer-Tropsche (FT) process enables conversion of syngas obtained from renewable sources (e.g. biomass gasification) into high-value fuel equivalent to gasoline. This process typically requires two-step reactions whereby syngas generated from biomass gasification is first converted to large chain hydrocarbon followed by hydrocracking and isomerisation reaction.

Sustainable, efficient phytochemical extraction technology and ingredients for functional food and supplement development

12.07.2017Published 13 days ago
Technology
TOSG20170712004
Offers
The Column-less extraction method is a liquid-to-liquid, non-ethanol base methodology that optimise yield of bioactives from botanicals. This technology that allows for a continuous cyclical production of bioactive extracts has been validated at one tonne production scale. It has demonstrated benefits of higher bioactive purity, shorter production cycle and lower production cost. Extracted ingredients are Halal-certifiable (the extraction technology does not utilise ethanol as the extraction solvent), and therefore accessible to a higher proportion of the global population.

Novel chemotherapeutic agent for skin cancer treatment.

11.07.2017Published 14 days ago
Technology
TOSG20170711001
Offers
Skin cancer is the most common form of cancer in the United States and it is ranked 6th in both men and women in Singapore. Since the currently used chemotherapy drugs for skin cancer treatment are non-selective, they attack normal cells as well which lead to various side effects.

A Singaporean company is looking for partners in Europe to distribute their enterprise software solutions through distribution services agreement.

04.07.2017Published 21 days ago
Commercial
BOSG20170620001
Offers
Established in Singapore in 2015, the Singaporean company is wholly owned by its parent company in Korea with regional offices in Japan and Singapore. The 2 software products are for enterprise solutions has implemented by over 3,500 clients across Asia-Pacific by various industries. Customers who have adopted these innovative solutions have achieved an increase in business revenue, productivity, and customer satisfaction in the long run.

Seeking algorithms for wheezing, cough and breathing pattern analysis for wearable asthma monitoring device

22.06.2017Published 33 days ago
Technology
TRSG20170622001
Requests
The asthma detection device developed by the Singapore company is wearable, non-intrusive and uses audio analysis for continuous monitoring of asthma patients. The company seeks acoustic signal processing algorithms to detect wheezing, cough and breathing patterns.

Use of silica nanoparticles for transforming municipal solid waste incineration (MSWI) fly ash into composite filler

09.06.2017Published 46 days ago
Technology
TOSG20170609001
Offers
In order to convert MSWI fly ash into useful materials, the toxic heavy metals in the ash have to be removed or stabilised. The current technologies such as electrochemical, sintering and vitrification have many limitations, i.e. high cost, high-energy consumption and the generation of more waste. The technology developed by the institution features a practical, scalable, low energy-consumption and economically viable solution to process the MSWI fly ash in a way that binds and immobilises toxic heavy metals that are present in the ash.

A Singapore medical company develops endovascular products for the treatment of strokes or cerebral aneurysms is searching for distributors through a distribution service agreement across Europe

05.06.2017Published 50 days ago
Commercial
BOSG20170502001
Offers
Incorporated in Singapore since 2002, this company develops innovative, life-saving and life-enhancing devices for endovascular therapy and the treatment and prevention of cerebral aneurysms.

Knowledge worker automation using artificial intelligence

29.05.2017Published 57 days ago
Technology
TOSG20170428001
Offers
The knowledge worker automation tool developed by the Singapore SME artificial intelligence solutions provider is a multi-lingual information extraction tool. It applies advanced semantic and reasoning algorithms, combined with machine learning and natural language processing to automatically identify, extract, cleanse, validate and store key pieces of information from unstructured and semi-structured documents (e.g. Profit and Loss, Balance Sheets, Powers of Attorneys, Policies).  The tool is able to extract information from a wide range and type of documents, in digital or physical.

Seeking applications from Asia Pacific innovative startups in diagnostics, materials, hair cleansing and non-invasive active molecule delivery methods for open innovation programme

12.05.2017Published 74 days ago
Technology
TRSG20170512001
Requests
The set of challenges that the Singapore-based large corporation is seeking to address with novel technologies or solutions are as follows. Interested applicants should be able to offer innovative technologies in the following areas: 1. Personalised diagnostics. 2. Smart materials 3. Green materials 4. Non-invasive delivery methods 5.

Stránky